A New York drugmaker is set to begin a clinical trial of a new antibody treatment. A treatment of last resort: A virus patient is recovering from a double lung transplant.
Source: New York Times
Live Coronavirus Updates: Schools Face Hurdles
More from Coronavirus (2019-nCoV)More posts in Coronavirus (2019-nCoV) »
Be First to Comment